Loading...
*  Topical Administration of Manuka Oil Prevents UV-B Irradiation-Induced Cutaneous Photoaging in Mice
... Oh Sook Kwon,1 Seung Hee ... S. R. Pinnell, "Cutaneous photodamage, oxidative stress, and topical antioxidant protection," Journal of the American Academy ... β-carotene in cutaneous photoprotection," Free Radical Biology and Medicine, vol. 25, no. 7, pp. 848-873, 1998. View at ...
  https://www.hindawi.com/journals/ecam/2013/930857/ref/
*  Publications | AIDS Clinical Trials Group
Administration, Cutaneous. Evans SR, Yeh T-min, Sacktor N, et al. "Selegiline transdermal system (STS) for HIV-associated ... Administration, Oral. Sacktor N, Miyahara S, Evans S, et al. "Impact of minocycline on cerebrospinal fluid markers of oxidative ...
  https://actgnetwork.org/pubmed_publications?page=4&s=keyword&o=asc
*  Effective Administration of Rituximab in Anti-MDA5 Antibody-Positive Dermatomyositis with Rapidly Progressive Interstitial Lung...
... his respiratory insufficiency and cutaneous involvement progressively worsened. However, the administration of rituximab (RTX) ... Effective Administration of Rituximab in Anti-MDA5 Antibody-Positive Dermatomyositis with Rapidly Progressive Interstitial Lung ... and refractory cutaneous involvement together with high levels of anti-melanoma differentiation-associated gene 5 antibody ( ... Disease and Refractory Cutaneous Involvement: A Case Report and Literature Review. Yuka Ogawa,1 Dai Kishida,1 Yasuhiro ...
  https://www.hindawi.com/journals/crirh/2017/5386797/abs/
*  Effective Administration of Rituximab in Anti-MDA5 Antibody-Positive Dermatomyositis with Rapidly Progressive Interstitial Lung...
... his respiratory insufficiency and cutaneous involvement progressively worsened. However, the administration of rituximab (RTX) ... Consequently, cutaneous involvements on his hands and elbows were remarkably improved (Figures 2(c) and 2(f)), and recovery ... Figure 2: Sequential findings of cutaneous lesions on the dorsum of the hand and elbow before the initiation of treatment (a, d ... Here we describe a case in which RTX ameliorated RP-ILD as well as refractory cutaneous involvement in a patient with anti-MDA5 ...
  https://www.hindawi.com/journals/crirh/2017/5386797/
*  Patent US20080306436 - Devices, Systems, and Methods for Medicament Delivery - Google Patents
Cutaneous administration system. US6726661 *. Dec 10, 2002. Apr 27, 2004. Novo Nordisk A/S. Air shot mechanism for electronic ... Device for the administration of drugs, particularly two-component drugs. US5383851 *. Jul 24, 1992. Jan 24, 1995. Bioject Inc. ... Administration instrument for medical use. US20060030819 *. Apr 1, 2005. Feb 9, 2006. Meridian Medical Technologies Inc.. ... Smart parenteral administration system. US9089636. Jul 5, 2005. Jul 28, 2015. Valeritas, Inc.. Methods and devices for ...
  http://www.google.com/patents/US20080306436?dq=3691140
*  Patent US5511726 - Nebulizer device - Google Patents
Cutaneous administration system. US6796303 *. 3 Jun 2002. 28 Sep 2004. Battelle Pulmonary Therapeutics, Inc.. Pulmonary aerosol ... Cutaneous administration system. US20040184999 *. 29 Jan 2004. 23 Sep 2004. Alexza Molecular Delivery Corporation. Delivery of ... Cutaneous administration system. US7550133. 20 Nov 2003. 23 Jun 2009. Alexza Pharmaceuticals, Inc.. Respiratory drug ...
  http://www.google.ca/patents/US5511726
*  Povidone-iodine Against Sodium Hypochlorite as Skin Antiseptics - Full Text View - ClinicalTrials.gov
Administration, cutaneous. Iodophors. Chlorine compounds. Anti-infecting agents, local. Additional relevant MeSH terms: ...
  https://clinicaltrials.gov/show/NCT00738543
*  A Smoking Cessation Trial in HIV-infected Patients in South Africa - Full Text View - ClinicalTrials.gov
administration, cutaneous. Additional relevant MeSH terms: Nicotine. Ganglionic Stimulants. Autonomic Agents. Peripheral ...
  https://clinicaltrials.gov/ct2/show/study/NCT01484340?view=results
*  Novel approach to improve permeation of ondansetron across shed snake skin as a model membrane.
Administration, Cutaneous. Animals. Ethanol / pharmacology. Humans. Models, Animal. Molting*. Oleic Acid / pharmacology. ...
  http://www.biomedsearch.com/nih/Novel-approach-to-improve-permeation/11428654.html
*  Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive...
Administration, Cutaneous. Analysis of Variance. Blotting, Western. Case-Control Studies. Dose-Response Relationship, Drug. ... cutaneous vascular conductance; P,0.05) and neuronal NO synthase-inhibited sites (94±4% versus 77±3% cutaneous vascular ... iNOS inhibition augmented the NO-dependent local heating response (93±2% versus 89±10% cutaneous vascular conductance). ... Upregulation of inducible nitric oxide synthase contributes to attenuated cutaneous vasodilation in essential hypertensive ...
  http://www.biomedsearch.com/nih/Upregulation-Inducible-Nitric-Oxide-Synthase/21931069.html
*  Burkitt lymphoma in a child with atopic dermatitis and a 7-year history of regular topical tacrolimus use.
Administration, Cutaneous. Burkitt Lymphoma / chemically induced, complications, diagnosis*, surgery. Child. Dermatitis, Atopic ... Immunosuppressive Agents / administration & dosage, adverse effects*. Intussusception / complications, diagnosis, surgery. Male ...
  http://www.biomedsearch.com/nih/Burkitt-lymphoma-in-child-with/22530327.html
*  Inhaled growth hormone (GH) compared with subcutaneous GH in children with GH deficiency: pharmacokinetics, pharmacodynamics,...
Administration, Cutaneous. Administration, Inhalation. Adolescent. Child. Cross-Over Studies. Dose-Response Relationship, Drug ... Human Growth Hormone / administration & dosage*, adverse effects*, deficiency, pharmacokinetics*. Humans. Male. Patient ...
  http://www.biomedsearch.com/nih/Inhaled-Growth-Hormone-GH-Compared/19336514.html
*  Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy |...
Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy. ... Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy ... Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy ... Severe Cutaneous and Neurologic Toxicity in Melanoma Patients during Vemurafenib Administration Following Anti-PD-1 Therapy ...
  http://cancerimmunolres.aacrjournals.org/content/early/2013/10/22/2326-6066.CIR-13-0092
*  EPO - T 1164/11 () of 18.2.2015
Medical apparatus for cutaneous administration of mendicaments. Applicant name:. C.I.R.C.E S.R.L.. ... which gave the energy to penetrate the cutaneous barrier and deliver the active principle to the target area, was rubbed on the ...
  http://www.epo.org/law-practice/case-law-appeals/recent/t111164eu1.html
*  Advantage 80 Large 🐱 Cats & Pet 🐰 Rabbits
The solution is indicated for cutaneous administration. Following topical application, the product is quickly distributed over ... Figure 3: Administration to dogs up to 25kg. For dogs of 25 kg body weight and greater. The dog should be standing for easy ... Figure 4: Administration to dogs over 25kg. For all dogs. Do not apply an excessive amount of solution at any one spot that ... Figure 2: Administration to the cat/rabbit. For dogs of less than 25kg body weight. With the dog in the standing position, part ...
  https://www.viovet.co.uk/Advantage-80-Large-Cats-Pet-Rabbits/c41744/?sct_t=1544142633&sct_q=advantage&sct_r=2
*  763. Cyfluthrin (Pesticide residues in food: 1987 evaluations Part II Toxicology)
Neurotoxicity study on chickens after cutaneous administration (cumulation tests). Unpublished report no. 10768 from Bayer ... About 5% was retained after i.v. administration, and about 0.5% was retained after intraduodenal administration. The study ... After i.v. administration, the plasma half-life [t(1/2)] of elimination was found to be biphasic, with a t(1/2) for the rapid ... A single oral administration of 0.5 or 10 mg/kg had little effect on elimination. The t(1/2) of absorption was calculated to be ...
  http://www.inchem.org/documents/jmpr/jmpmono/v87pr08.htm
*  Die ältere Patientin mit Wallungen | SpringerLink
Menopause Conjugated equine estrogens Administration, cutaneous Venous thromboembolism Stroke Mortality Cardiovascular risk ... Renoux C, Suissa S (2011) Hormone Therapy administration in postmenopausal women and risk of stroke. Women's Health 7(3):355- ...
  https://link.springer.com/article/10.1007/s10304-018-0184-0
*  The ternary phase diagram under different proportion co | Open-i
Administration, Cutaneous. *Animals. *Castor Oil/analogs & derivatives/chemistry. *Drug Stability. *Female. *Mice ...
  https://openi.nlm.nih.gov/detailedresult.php?img=PMC3107722_ijn-6-649f3&req=4
*  Comparison of insulin release profiles obtained with th | Open-i
Comparison of insulin release profiles obtained with the Franz diffusion cell.(a) Comparison of cumulative insulin release profiles of the DMN patch compared wi
  https://openi.nlm.nih.gov/detailedresult.php?img=PMC4300505_srep07914-f4&req=4
*  Hyperactivation of P21ras and the Hematopoietic-Specific Rho Gtpase, Rac2, Cooperate to Alter the Proliferation of...
Mice in Response to Local Cutaneous Administration of SCF Is Mediated through Rac2 In Vivo.. Local cutaneous injection of SCF ... C) Number of cutaneous mast cells per mm2 in Nf1+/− and wild-type mice in response to local administration of various ... Effect of heterozygosity of Nf1 on accumulation of cutaneous mast cells in response to local administration of SCF in vivo. (A ... Representative skin biopsy stained for cutaneous mast cells taken from the site of SCF administration via a microosmotic pump ...
  http://jem.rupress.org/content/194/1/57
*  Photograph of(A) a single microneedle coated with influ | Open-i
Administration, Cutaneous*. *Influenza A Virus, H3N2 Subtype/immunology*. *Influenza Vaccines/administration & dosage* ... In view of the convenience of delivery and the potential for self-administration, vaccine-coated metal microneedles may provide ... In view of the convenience of delivery and the potential for self-administration, vaccine-coated metal microneedles may provide ... and induction of virus-specific memory B-cells.In view of the convenience of delivery and the potential for self-administration ...
  https://openi.nlm.nih.gov/detailedresult.php?img=PMC2651574_pone.0004773.g001&req=4
*  angiokeratoma in tub sclerosis 2005:2010[pubdate] *count=100 - BioMedLib™ search engine
MeSH-minor] Administration, Cutaneous. Animals. Cell Line, Tumor. Disease Models, Animal. Mice. Mice, Nude. Neoplasm ... Sirolimus / administration & dosage. Tuberous Sclerosis / complications. *[MeSH-minor] Administration, Topical. Adolescent. ... Enzyme Inhibitors / administration & dosage. Protein Kinases / drug effects. Sirolimus / administration & dosage. Soft Tissue ... Sun XF, Yan CL, Fang L, Shen FM, Liao KH: Cutaneous lesions and visceral involvement of tuberous sclerosis. Chin Med J (Engl); ...
  http://www.bmlsearch.com/?kwr=angiokeratoma+in+tub+sclerosis+2005:2010%5Bpubdate%5D&cxts=100&stmp=b0